Risks in risk stratification: what is relevant in practice?
Mäkikallio
Timo H
TH
Huikuri
Heikki V
HV
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D001145:Arrhythmias, Cardiac / Q000175:diagnosis* / Q000503:physiopathology / Q000628:therapy; D002986:Clinical Trials as Topic / Q000592:standards; D016757:Death, Sudden, Cardiac / Q000517:prevention & control; D017147:Defibrillators, Implantable / Q000191:economics; D006801:Humans; D011237:Predictive Value of Tests; D012107:Research Design; D018570:Risk Assessment / Q000379:methods / Q000592:standards
D000319:Adrenergic beta-Antagonists